MAP1LC3A and cancer: S130 results in the accumulation of lipidated LC3 in cells, indicating disruption of autophagic flux, and has strong anti-proliferative activity in a variety of cancer cell lines, as well as in vivo growth of colorectal cancer xenografts [101].